-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Ambrx Biopharma Cayman, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2021 to 2022.
- Ambrx Biopharma Cayman, Inc. Earnings Per Share, Basic for the quarter ending June 30, 2023 was -0.05 USD/shares, a 54.5% increase year-over-year.
- Ambrx Biopharma Cayman, Inc. annual Earnings Per Share, Basic for 2022 was -0.29 USD/shares, a 39.6% increase from 2021.
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)